Skip to content
★ Sign in to follow
董

董胜军

Executive
Chief Executive Officer
昊帆生物
Total declarations
3
Company
1
▲ Purchases (3 ops.)
€726k
▼ Sales (0 ops.)
—

Latest filing published 16 Jul 2024 for 昊帆生物, €168k.

Filing timeline

BuySale
董胜军

Insider track record

Disclosed buys
3
Disclosed sells
0
Signal history

Closed purchases

Market purchases
3
Positive at T+90
100%
Median T+90
+25.0%

Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 16 Jul 2024 · 847 days ago · €168k
    +38.5%
    Entry CN¥40.12 · Close at T+365 CN¥55.57
  • Filed 09 Jul 2024 · 854 days ago · €67k
    +31.3%
    Entry CN¥40.02 · Close at T+365 CN¥52.53
  • Filed 08 Jul 2024 · 855 days ago · €492k
    +28.0%
    Entry CN¥40.40 · Close at T+365 CN¥51.70

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

董胜军: trading record in brief

董胜军, listed as chief executive, appears in our data through filings on 昊帆生物 shares, published by SSE / SZSE (CSRC). Between 8 July 2024 and 16 July 2024, the trades on record add up to 3 filings.

On the market, this insider has only ever bought: 3 purchases, €726k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price.

The median purchase comes to €168k. Of 3 purchases, 3 formed part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. Ninety days after publication, 3 purchases show a median change of +25.0%, with the price up in 100% of them. These figures describe past trades and do not predict future prices.

The latest filing, published on 16 July 2024, reports an open-market purchase of €168k in 昊帆生物. Most trades are made public on the day they happen. This delay matters because a trade only becomes useful information once it is public. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.

Companies and markets linked to 董胜军

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations3 total
  • ▲
    董秘,高管Executives昊帆生物
    1M CNY31SZSE
    32,400 shares23.1% of flowA股XSHESZSE:173000007850847460
    Canonical exit: 14 Oct 2024 (T+90)
  • ▲
    董秘,高管Executives昊帆生物
    524,550 CNY30SZSE
    13,000 shares9.2% of flowA股XSHESZSE:173000007830646720
    Canonical exit: 7 Oct 2024 (T+90)
  • ▲
    董秘,高管Executives昊帆生物
    4M CNY33SZSE
    97,100 shares67.7% of flowA股XSHESZSE:173000007827720500
    Canonical exit: 6 Oct 2024 (T+90)

3 of 3 declarations